{"id":"https://openalex.org/W7204258366","doi":"https://doi.org/10.4081/reumatismo.2026.2395","title":"Anifrolumab as a therapeutic option in mixed connective tissue disease with autoimmune cytopenia: a case report and narrative review of the literature","display_name":"Anifrolumab as a therapeutic option in mixed connective tissue disease with autoimmune cytopenia: a case report and narrative review of the literature","publication_year":2026,"publication_date":"2026-08-26","ids":{"openalex":"https://openalex.org/W7204258366","doi":"https://doi.org/10.4081/reumatismo.2026.2395","pmid":"https://pubmed.ncbi.nlm.nih.gov/42657973"},"language":"en","primary_location":{"id":"doi:10.4081/reumatismo.2026.2395","doi":"https://doi.org/10.4081/reumatismo.2026.2395","is_oa":true,"landing_page_url":"https://doi.org/10.4081/reumatismo.2026.2395","pdf_url":"https://www.collectionscanada.ca/obj/thesescanada/vol2/OTU/TC-OTU-18786.pdf","source":{"id":"https://openalex.org/S2738672850","display_name":"Reumatismo","issn_l":"0048-7449","issn":["0048-7449","2240-2683"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reumatismo","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.collectionscanada.ca/obj/thesescanada/vol2/OTU/TC-OTU-18786.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022760883","display_name":"Noemi Italiano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129627893","display_name":"University of Molise","ror":"https://ror.org/04z08z627","country_code":"IT","type":"education","lineage":["https://openalex.org/I129627893"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Noemi Italiano","raw_affiliation_strings":["Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise, Campobasso"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise, Campobasso","institution_ids":["https://openalex.org/I129627893"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015866836","display_name":"Fabio Massimo Perrotta","orcid":"https://orcid.org/0000-0003-3771-5205","observed_orcids":["https://orcid.org/0000-0003-3771-5205"]},"institutions":[{"id":"https://openalex.org/I129627893","display_name":"University of Molise","ror":"https://ror.org/04z08z627","country_code":"IT","type":"education","lineage":["https://openalex.org/I129627893"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabio Massimo Perrotta","raw_affiliation_strings":["Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise, Campobasso"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise, Campobasso","institution_ids":["https://openalex.org/I129627893"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044824409","display_name":"Mauro Fatica","orcid":"https://orcid.org/0000-0001-9631-6891","observed_orcids":["https://orcid.org/0000-0001-9631-6891"]},"institutions":[{"id":"https://openalex.org/I116067653","display_name":"University of Rome Tor Vergata","ror":"https://ror.org/02p77k626","country_code":"IT","type":"education","lineage":["https://openalex.org/I116067653"]},{"id":"https://openalex.org/I129627893","display_name":"University of Molise","ror":"https://ror.org/04z08z627","country_code":"IT","type":"education","lineage":["https://openalex.org/I129627893"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mauro Fatica","raw_affiliation_strings":["Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise, Campobasso; Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise, Campobasso; Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome","institution_ids":["https://openalex.org/I116067653","https://openalex.org/I129627893"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088736161","display_name":"Ennio Lubrano","orcid":"https://orcid.org/0000-0001-6189-5328","observed_orcids":["https://orcid.org/0000-0001-6189-5328","https://orcid.org/0000-0002-8050-9637"]},"institutions":[{"id":"https://openalex.org/I129627893","display_name":"University of Molise","ror":"https://ror.org/04z08z627","country_code":"IT","type":"education","lineage":["https://openalex.org/I129627893"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ennio Lubrano","raw_affiliation_strings":["Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise, Campobasso"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Rheumatology Unit, Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, University of Molise, Campobasso","institution_ids":["https://openalex.org/I129627893"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1693,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.90480065,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"78","issue":"3","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anifrolumab","display_name":"anifrolumab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/mixed-connective-tissue-disease","display_name":"mixed connective tissue disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/autoimmune-cytopenia","display_name":"autoimmune cytopenia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/systemic-sclerosis","display_name":"systemic sclerosis","score":0.7609999775886536},{"id":"https://openalex.org/keywords/pancytopenia","display_name":"pancytopenia","score":0.9070000052452087},{"id":"https://openalex.org/keywords/lymphopenia","display_name":"lymphopenia","score":0.7850000262260437},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.8489999771118164},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":0.7239999771118164},{"id":"https://openalex.org/keywords/mycophenolate","display_name":"mycophenolate","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pulmonary-arterial-hypertension","display_name":"pulmonary arterial hypertension","score":0.656000018119812},{"id":"https://openalex.org/keywords/esophageal-involvement","display_name":"esophageal involvement","score":0.8629999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9646999835968018},{"id":"https://openalex.org/C2776153627","wikidata":"https://www.wikidata.org/wiki/Q1622407","display_name":"Mixed connective tissue disease","level":3,"score":0.8277000188827515},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.7077999711036682},{"id":"https://openalex.org/C2776670291","wikidata":"https://www.wikidata.org/wiki/Q1779300","display_name":"Connective tissue disease","level":4,"score":0.5195000171661377},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5055000185966492},{"id":"https://openalex.org/C518705261","wikidata":"https://www.wikidata.org/wiki/Q25615","display_name":"Connective tissue","level":2,"score":0.4700999855995178},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4580000042915344},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.36320000886917114},{"id":"https://openalex.org/C2778962941","wikidata":"https://www.wikidata.org/wiki/Q16543725","display_name":"Undifferentiated connective tissue disease","level":5,"score":0.3537999987602234},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.3515999913215637},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.34850001335144043},{"id":"https://openalex.org/C2780194698","wikidata":"https://www.wikidata.org/wiki/Q6005429","display_name":"Immune dysregulation","level":3,"score":0.3418999910354614},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.3343000113964081},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3325999975204468},{"id":"https://openalex.org/C2777385706","wikidata":"https://www.wikidata.org/wiki/Q28814","display_name":"Autoimmune hemolytic anemia","level":3,"score":0.32519999146461487},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.30329999327659607},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3021000027656555},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.29499998688697815},{"id":"https://openalex.org/C2780372218","wikidata":"https://www.wikidata.org/wiki/Q417222","display_name":"Methylprednisolone","level":2,"score":0.289000004529953},{"id":"https://openalex.org/C2909935303","wikidata":"https://www.wikidata.org/wiki/Q420553","display_name":"Mycophenolate","level":3,"score":0.28769999742507935},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.28369998931884766},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.27900001406669617},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.26820001006126404},{"id":"https://openalex.org/C140608501","wikidata":"https://www.wikidata.org/wiki/Q7318358","display_name":"Review article","level":2,"score":0.2635999917984009},{"id":"https://openalex.org/C2779701055","wikidata":"https://www.wikidata.org/wiki/Q929833","display_name":"Rare disease","level":3,"score":0.2587999999523163},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.25679999589920044},{"id":"https://openalex.org/C2909916134","wikidata":"https://www.wikidata.org/wiki/Q338912","display_name":"Intravenous Immunoglobulin Therapy","level":3,"score":0.2533999979496002}],"mesh":[{"descriptor_ui":"D000095542","descriptor_name":"Cytopenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D007970","descriptor_name":"Leukopenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007970","descriptor_name":"Leukopenia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008947","descriptor_name":"Mixed Connective Tissue Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D008947","descriptor_name":"Mixed Connective Tissue Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010198","descriptor_name":"Pancytopenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010198","descriptor_name":"Pancytopenia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012595","descriptor_name":"Scleroderma, Systemic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.4081/reumatismo.2026.2395","doi":"https://doi.org/10.4081/reumatismo.2026.2395","is_oa":true,"landing_page_url":"https://doi.org/10.4081/reumatismo.2026.2395","pdf_url":"https://www.collectionscanada.ca/obj/thesescanada/vol2/OTU/TC-OTU-18786.pdf","source":{"id":"https://openalex.org/S2738672850","display_name":"Reumatismo","issn_l":"0048-7449","issn":["0048-7449","2240-2683"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reumatismo","raw_type":"journal-article"},{"id":"pmid:42657973","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42657973","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reumatismo","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:5ccafc0e20d541d6bcb109f8bed1bc56","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5ccafc0e20d541d6bcb109f8bed1bc56","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Reumatismo (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.4081/reumatismo.2026.2395","doi":"https://doi.org/10.4081/reumatismo.2026.2395","is_oa":true,"landing_page_url":"https://doi.org/10.4081/reumatismo.2026.2395","pdf_url":"https://www.collectionscanada.ca/obj/thesescanada/vol2/OTU/TC-OTU-18786.pdf","source":{"id":"https://openalex.org/S2738672850","display_name":"Reumatismo","issn_l":"0048-7449","issn":["0048-7449","2240-2683"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reumatismo","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8293135166168213}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204258366.pdf","grobid_xml":"https://content.openalex.org/works/W7204258366.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W2012436439","https://openalex.org/W2086527370","https://openalex.org/W2753123903","https://openalex.org/W2766823743","https://openalex.org/W2894826086","https://openalex.org/W3006003722","https://openalex.org/W3207022084","https://openalex.org/W4379739799","https://openalex.org/W4392041567","https://openalex.org/W4394745031","https://openalex.org/W4399070786","https://openalex.org/W4401666563","https://openalex.org/W4408074236","https://openalex.org/W4412615254"],"related_works":[],"abstract_inverted_index":{"Mixed":[0],"connective":[1,178],"tissue":[2,179],"disease":[3,97],"(MCTD)":[4],"represents":[5,65],"a":[6,58,66,72,169],"complex":[7],"autoimmune":[8],"condition":[9],"characterized":[10],"by":[11,44,101],"vasculopathy,":[12],"fibrosis,":[13],"and":[14,28,38,62,77,92,110,150,154],"immune":[15],"dysregulation.":[16],"Autoimmune":[17],"cytopenias":[18],"are":[19],"rare":[20],"but":[21],"clinically":[22],"significant":[23],"complications":[24],"that":[25],"increase":[26],"morbidity":[27],"complicate":[29],"management":[30],"of":[31,80,134,148,152,177],"these":[32],"diseases.":[33],"Current":[34],"therapies,":[35],"including":[36,104],"glucocorticoids":[37,121],"conventional":[39],"immunosuppressants,":[40],"may":[41],"be":[42],"limited":[43],"intolerance":[45],"or":[46],"inadequate":[47],"hematologic":[48,125,144,175],"response.":[49],"Type":[50],"I":[51,165],"interferon":[52],"(IFN)":[53],"signaling":[54],"has":[55],"emerged":[56],"as":[57,168],"key":[59],"pathogenic":[60],"pathway,":[61],"its":[63],"blockade":[64,167],"novel":[67],"therapeutic":[68,171],"approach.":[69],"We":[70],"describe":[71],"39-year-old":[73],"woman":[74],"with":[75,84,129,146],"MCTD":[76],"clinical":[78],"features":[79],"systemic":[81],"sclerosis,":[82],"presenting":[83],"Raynaud's":[85],"phenomenon,":[86],"digital":[87],"ischemic":[88],"ulcers,":[89],"esophageal":[90],"involvement,":[91],"pulmonary":[93],"arterial":[94],"hypertension.":[95],"Her":[96],"course":[98],"was":[99,131],"complicated":[100],"progressive":[102],"cytopenia,":[103],"leukopenia,":[105],"severe":[106],"lymphopenia,":[107],"mild":[108],"anemia,":[109],"thrombocytopenia.":[111],"Azathioprine":[112],"therapy":[113],"led":[114],"to":[115],"worsening":[116],"pancytopenia,":[117],"necessitating":[118],"discontinuation,":[119],"while":[120],"provided":[122],"only":[123],"partial":[124],"recovery.":[126],"Subsequent":[127],"treatment":[128],"mycophenolate":[130],"ineffective.":[132],"Introduction":[133],"anifrolumab":[135],"(300":[136],"mg":[137],"IV":[138],"every":[139],"4":[140],"weeks)":[141],"resulted":[142],"in":[143,173,184],"improvement,":[145],"normalization":[147],"hemoglobin":[149],"stabilization":[151],"leukocyte":[153],"platelet":[155],"counts,":[156],"without":[157],"infusion-related":[158],"adverse":[159],"events.":[160],"The":[161],"findings":[162],"support":[163],"type":[164],"IFN":[166],"promising":[170],"avenue":[172],"refractory":[174],"manifestations":[176],"disease,":[180],"warranting":[181],"further":[182],"investigation":[183],"larger":[185],"studies.":[186]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2026-08-27T00:00:00"}